Publication date: Jul 03, 2025
COVID-19 remains common in the US, but up-to-date data on health care resource utilization and cost remain limited, particularly during Omicron predominance. This study was conducted using administrative claims data from the HealthVerity database. All available records in medical claims, pharmacy claims, laboratory tests, charge data master, and related enrollment, including COVID-19 events, from December 24, 2021 to April 30, 2022, were extracted. Outpatient and inpatient health care resource utilization (HCRU) and cost for the 28-day follow-up period after COVID-19 index date were calculated. A total of 1,203,769 patients with COVID-19 were included in the HCRU analysis; of these, 377,945 had non-missing cost data and were included in the costing analysis. The median age was 43 years, and 90. 3% were
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| pathway | REACTOME | Reproduction |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | Comorbidity |